Herbas VPB

Print
EN | LT
LT - Geriamasis sertralino koncentratas
EN - SERTRALINE ORAL CONCENTRATE

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 9/08 (2006.01)
A61K 9/00 (2006.01)
A61K 31/135 (2006.01)
A61K 47/02 (2006.01)
A61K 47/08 (2006.01)
A61K 47/10 (2006.01)
A61K 47/12 (2006.01)
A61K 47/18 (2006.01)
A61K 47/20 (2006.01)
A61K 47/22 (2006.01)
A61K 47/34 (2006.01)
A61P 1/14 (2006.01)
A61P 9/10 (2006.01)
A61P 25/18 (2006.01)
A61P 25/22 (2006.01)
A61P 25/24 (2006.01)
A61P 25/30 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 1121107
(13) Kind of document T
(96) European patent application number 99943168.7
Date of filing the European patent application 1999-09-22
(97) Date of publication of the European application 2001-08-08
(45) Date of publication and mention of the grant of the patent 2003-11-19
(46) Date of publication of the claims translation 2004-03-25
PCT application
(86) Number PCT/IB9901/571
Date 1999-09-22
PCT application publication
(87) Number WO 0002/1521
Date 2000-04-20
Priority applications
(30) Number Date Country code
104024 P 1998-10-13 US
Inventors
(72)
HARPER, Nancy, Jane, US
RANADE, Gautam, Ramchandra, US
WELCH, Willard, McKowan, US
Grantee
(73) Pfizer Products Inc., Eastern Point Road, Groton, CT 06340, US
Attorney or representative
(74) Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Geriamasis sertralino koncentratas
  SERTRALINE ORAL CONCENTRATE
Last renewal fee
Payment date Validity (years) Amount
2007-08-16 9 720.00 LTL
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2008-09-22